Genistein improves renal disease in a mouse model of nephropathic cystinosis: a comparison study with cysteamine

Cysteamine is currently the only therapy for nephropathic cystinosis. It significantly improves life expectancy and delays progression to end-stage kidney disease; however, it cannot prevent it. Unfortunately, compliance to therapy is often weak, particularly during adolescence. Therefore, finding b...

Descripción completa

Detalles Bibliográficos
Autores principales: De Leo, Ester, Taranta, Anna, Raso, Roberto, Polishchuk, Elena, D’Oria, Valentina, Pezzullo, Marco, Goffredo, Bianca Maria, Cairoli, Sara, Bellomo, Francesco, Battafarano, Giulia, Camassei, Francesca Diomedi, Del Fattore, Andrea, Polishchuk, Roman, Emma, Francesco, Rega, Laura Rita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026248/
https://www.ncbi.nlm.nih.gov/pubmed/36300303
http://dx.doi.org/10.1093/hmg/ddac266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026248/
https://www.ncbi.nlm.nih.gov/pubmed/36300303
http://dx.doi.org/10.1093/hmg/ddac266

Ejemplares similares